← Back to all trials
Recruiting
NCT06657378
A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures
Conditions: Partial-Onset Seizures, Primary Generalized Tonic-clonic Seizures
Sex: All
Ages: 4 Years – N/A
Healthy volunteers: No
Enrollment: 110
Sponsor: Eisai Co., Ltd.
Location: 1 Tokyo
Summary
The purpose of this study is to determine the safety of Fycompa for injection after administration in participants with epilepsy (partial-onset seizures \[including secondarily generalized seizures\]) (age 4 years or older) or primary generalized tonic-clonic seizures (age 12 years or older).
Eligibility Criteria
Inclusion Criteria:
* Participants with epilepsy who received the Fycompa for injection for the first time will be included.
Exclusion Criteria:
* The exclusion criteria will not be specified in particular because this survey will be conducted in daily clinical practice.
Source: ClinicalTrials.gov (NCT06657378). StuddyBuddy aggregates publicly available trial information.
